About us

  • Arquer Diagnostics (Arquer) is a private, UK-based diagnostics company focused on the development and commercialisation of non-invasive immunoassay diagnostic tests for cancer diagnosis and monitoring.
  • Arquer’s tests are based on minichromosome maintenance (MCM) protein, a marker for the presence of dividing cancer cells. This patent protected, intellectual property is licensed exclusively from Cancer Research Technology (CRT), the development and commercialisation arm of Cancer Research UK.
  • Our initial focus is on the development of lab based tests for urological (prostate and bladder) cancers.